Pulmonary/Respiratory Drug Delivery Market Worth 52.37 Billion USD by 2021 - Seite 2

Currently, North America dominates the Pulmonary Drug Delivery Market, and Asia represents the second-largest regional market. North America is further classified as U.S. and Canada.

The U.S. is expected to account for the largest share of the North American Pulmonary Drug Delivery Market in 2016. The large share of this market can be attributed to factors such as growing prevalence of lung and respiratory diseases, technological developments, and the presence of various players focusing on the development of digital inhalers in the country.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=179682410

Moreover, the Asian market is expected to register the highest CAGR during the forecast period due to the rapidly growing geriatric population, growing adoption of an unhealthy lifestyle, growing urbanization, exposure to smoke & chemicals, and the subsequent increase in the prevalence of COPD in the region. Asia is further classified into Japan,India, and China, Japan is expected to account for the largest share of the Asian Pulmonary Drug Delivery Market in 2016. This largest share is attributed to favorable healthcare reimbursement scenarios and insurance coverage. Insurance coverage is mandated by the government and regulated under the Universal Health Insurance System

Prominent players in the Pulmonary Drug Delivery Market include Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (U.K.), Boehringer Ingelheim GmbH (Germany), 3M (U.S.), AstraZeneca plc (U.K.), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Omron Corporation (Japan), and Sunovion Pharmaceuticals Inc. (U.S.).

Browse Related Reports: 

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/respiratory-care-368.html

Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

http://www.marketsandmarkets.com/Market-Reports/respiratory-diagnostics-market-163390459.html

About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.